A practical framework for Lp(a) screening and cardiovascular (CV) risk assessment and management in Canada highlights inconsistent Lp(a) testing across the country, especially in rural and remote communities, and urges Lp(a) testing to be included on standard laboratory requisitions and automated Lp(a) companion orders at the time of the first lipid panel.1
